ArticleMolecular imaging and biology2026
Brain Amyloid Deposition Is Negatively Associated with Cardiac Amyloid Retention in Apo E4 Carriers: A Pilot Study.
Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeWe investigated the relationship between amyloid deposition in the brain and heart using positron emission tomography (PET) scan with a focus on the influence of the apolipoprotein (Apo) E4 genotype. PROCEDURE: Twenty-eight participants (12 healthy controls, 11 patients with mild cognitive impairment, and 5 patients with Alzheimer's disease) were recruited. Each subject visited the institution three times on separate days for echocardiography, brain and cardiac
resultsThe mean MTR of all participants was 24.0%, with no significant difference between Apo E4 carriers and non-carriers. Within this pilot study, an inverse association was identified between MTR and brain amyloid deposition on the Centiloid scale specifically among Apo E4 carriers. In contrast, no significant association was found in Apo E4 non-carriers, consistent with the findings from the full-volume analysis.
conclusionIn this pilot study, an inverse association was observed between brain amyloid β deposition and cardiac amyloid retention in Apo E4 carriers, but not in non-carriers. These findings represent an exploratory clinical observation regarding potential genotype-specific patterns in central and peripheral amyloid dynamics. While the results are hypothesis-generating, they highlight the need for further research into the brain-heart axis in amyloid-related diseases, particularly in genetically at-risk individuals using larger confirmatory cohorts.
Indexed as
Identifiers
42135537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.